Global Glycated Hemoglobin Testing Equipment Market Size study & Forecast, by Product Type (Multifunctional Testing Equipment, Simple Testing Equipment), by Technology Type (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassay, Boronate

Global Glycated Hemoglobin Testing Equipment Market Size study & Forecast, by Product Type (Multifunctional Testing Equipment, Simple Testing Equipment), by Technology Type (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay), by End-User (Hospitals, Physical Examination Institutions, Research Institutions, Others) and Regional Analysis, 2023-2030

Global Glycated Hemoglobin Testing Equipment Market is valued at approximately USD xx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2023-2030. Glycated hemoglobin, often referred to as hemoglobin A1c (HbA1c), is a form of hemoglobin that is used to measure average blood glucose levels over a prolonged period. Hemoglobin is a protein found in red blood cells responsible for carrying oxygen throughout the body. When glucose molecules in the bloodstream bind to hemoglobin, a process called glycation occurs, resulting in the formation of glycated hemoglobin. The level of glycated hemoglobin reflects the average blood glucose concentration over the lifespan of red blood cells, which is typically around two to three months. The Glycated Hemoglobin Testing Equipment market is expanding because of factors such as rising prevalence of diabetes and rising geriatric population.

According to the International Diabetes Federation's edition from 2019, there were around 463 adults living with diabetes, and by 2045, there would be 700 million adults worldwide. The World Bank Group projects that the world's elderly population, which was 727 million in 2020, will triple over the next three decades and reach 1.5 billion in 2050. Thus, rising prevalence of diabetes and rising geriatric population in the region is fostering market growth. In addition, increased R&D on diabetes, sedentary lifestyles, poor diet that results in subpar healthcare conditions, and improvements in technology for diagnosing diabetes are creating a lucrative opportunity for market growth. However, the high cost of Glycated Hemoglobin Testing Equipment and lack of diabetic care awareness stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Glycated Hemoglobin Testing Equipment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 as a result of the popularity of branded goods and the region's rising disease rates in the region, and rising research and development activities in the region. Asia Pacific is anticipated to witness significant growth during the forecast period as a result of factors including growing geriatric population and rising prevelance of chronic disease, an increase in the number of collaborations and partnership for product development, geographic expansion of key players, and active participation of governments in the market space.

Major market players included in this report are:
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Alere Inc.
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
Bayer AG
Randox Laboratories Ltd.
Tosoh Corporation
ARKRAY, Inc.
A.Menarini Diagnostics Ltd.

Recent Developments in the Market:
In June 2021, the U.S. Food and Drug Administration approved Abbott Laboratories' Afinion HbA1c Dx assay for use as a point-of-care test. They declared that the Afinion 2 analyzer would endorse this product.

Global Glycated Hemoglobin Testing Equipment Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Product Type, Technology Type, End-User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Typeofferings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Multifunctional Testing Equipment
Simple Testing Equipment

By Technology Type:
Ion-Exchange High Performance Liquid Chromatography (HPLC)
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay

By End-User:
Hospitals
Physical Examination Institutions
Research Institutions
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Alere Inc.
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
Bayer AG
Randox Laboratories Ltd.
Tosoh Corporation
ARKRAY, Inc.
A.Menarini Diagnostics Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.